As ADAR2 overexpression has no adverse effects on motor, lung, or heart functions, except for simple obesity due to chronic hyperphagia in ADARB1 transgenic mice [165], ADAR2 activity is safely restored by gene therapy. The gene discussed is ADARB1; the disease is obesity disorder.